1. Home
  2. BSY vs MEDP Comparison

BSY vs MEDP Comparison

Compare BSY & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bentley Systems Incorporated Class B

BSY

Bentley Systems Incorporated Class B

HOLD

Current Price

$34.79

Market Cap

11.8B

Sector

Technology

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$451.39

Market Cap

12.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSY
MEDP
Founded
1984
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
12.9B
IPO Year
2002
2016

Fundamental Metrics

Financial Performance
Metric
BSY
MEDP
Price
$34.79
$451.39
Analyst Decision
Buy
Hold
Analyst Count
12
13
Target Price
$49.08
$498.25
AVG Volume (30 Days)
2.7M
267.7K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
0.77%
N/A
EPS Growth
18.06
20.98
EPS
0.85
15.28
Revenue
$734,849,000.00
N/A
Revenue This Year
$14.13
$13.15
Revenue Next Year
$10.44
$7.47
P/E Ratio
$42.52
$30.60
Revenue Growth
6.24
N/A
52 Week Low
$30.97
$250.05
52 Week High
$59.25
$628.92

Technical Indicators

Market Signals
Indicator
BSY
MEDP
Relative Strength Index (RSI) 39.60 41.21
Support Level $31.48 $418.96
Resistance Level $35.08 $477.04
Average True Range (ATR) 1.24 15.17
MACD -0.43 3.02
Stochastic Oscillator 6.67 20.99

Price Performance

Historical Comparison
BSY
MEDP

About BSY Bentley Systems Incorporated Class B

Bentley Systems is a software vendor that caters to civil engineers, constructors, and geospatial professionals by enabling design, simulation, and data management of infrastructure assets such as roads and bridges. While Bentley is smaller than many other design software companies, it is a market leader across a handful of specialty areas, including public works, electricity grids, and transit.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: